Virax Holdings is another biotech that has just bounced off it's lows(up 4c to 52c today on low volume). On Tuesday it announced that it had recruited patients for it's HIV treatment trial. The results aren't out until November/December but at these levels there can't be much downside so I got some as a medium term hold. Apparently Virax's treatment kills the AIDS virus rather than just suppressing it as in most other treatments so it eliminates the need for drugs to be taken indefinitely. Probably a risky investment but with a BIG upside on a successful trial. I hold VHL. Do your own research before investing.
VHL Price at posting:
0.0¢ Sentiment: None Disclosure: Held
